subject: Development And Reform Commission Thoroughly Investigated Drug Prices Played The Prelude To Adjust [print this page] 3 4, General Development and Reform Commission issued a "cost-price drugs on the investigation carried out," which called for provincial and municipal units, organizations, pharmaceutical companies and medical institutions, pharmaceutical costs and prices in completing the questionnaire. In the new round of price adjustment, the high price of drugs to further reduce the retail price, the appropriate low-cost essential drugs to improve clinical value has become the consensus decision-making.
HC pharmaceutical industry network
"We have received the questionnaire, the process of being down." March 18, told a reporter for pharmaceutical companies.
3 4, General Development and Reform Commission issued a "cost-price drugs on the investigation carried out," which called for provincial and municipal units, organizations, pharmaceutical companies and medical institutions, pharmaceutical costs and prices in completing the questionnaire. Survey for all listed in the national basic medical insurance and industrial injury insurance pharmaceutical drug directory.
In the new medical reform plan on the eve of the forthcoming Development and Reform Commission to launch a new round of such a large scale survey of drug prices, raised concerns in the industry. The reporter from the National Development and Reform Commission was informed by stakeholders in the new round of price adjustment, the high price of drugs to further reduce the retail price, the appropriate low-cost essential drugs to improve clinical value has become the consensus decision-making.
Thoroughly investigated
3 month, a business reporter obtained from the notice paper. Notice explained that Medicare drug prices in this survey is to meet the medical and health system reform and the implementation of the national essential drugs, understand and master the process of pharmaceutical production and distribution costs, prices, facilitate timely adjustment of the Government to develop pricing.
Notice, the NDRC asked please provinces (autonomous regions and municipalities) in charge of prices the market price, bid price, the provincial pricing (for the record price) survey and investigation of electronic data description (including the survey, survey data, covering species, etc.) Summary Assessment Center drug prices to SDRC. Deadline is March 30, 2009.
Currently, Sichuan, Guangdong, Fujian and Chongqing Municipality and so has led to the questionnaire sent to the area pharmaceutical companies and hospitals.
View from the questionnaires, the content division is very detailed. The cost of production in accordance with domestic drug companies, joint ventures and imports of all categories of imports such as were reported to require companies fill in raw material prices, labor prices, travel costs and other details. It is understood that health insurance directory including 1031 kinds of medicine and 823 kinds of Traditional Chinese medicine . List of all drugs in all dosage forms specifications are listed in the scope of the survey.
However, pharmaceutical companies, who declined to name the reporter who said that the data reporting has always been a "mere formality", a lot of hidden costs not reflected, and the data is difficult to completely verify the true and false. But he believes that at this time for research, Development and Reform Commission future policy intentions, concern.
Is worth mentioning that the first large-scale research Pharmaceutical Development and Reform Commission in April 2006 and the second was in May 2007. These two studies, the Development and Reform Commission has several times lower drug prices, but did not reduce medical treatment costs, pharmaceutical companies raised doubts.
"Since 2007, we have not put off price reduction policy is to consider giving some breathing time for pharmaceutical companies. On the other hand, allowing businesses to adjust strategies to adapt to the larger environment of opportunities." Earlier, the State issued NDRC Price Department of Traditional Chinese Medicine Division have told a reporter, said.
Two years later, it is clear Development and Reform Commission, "on the price adjustment once every two years," the deadline, the industry generally believe that a large-scale research should be a prelude to the next round of price adjustment.
